[1] 王静.  人文关怀在甲状腺癌术后行131碘治疗患者中的临床效果[J]. 临床医学工程, 2018, 25(6): 827-828.   doi: 10.3969/j.issn.1674-4659.2018.06.0827
Wang J.  Clinical effect of humanistic care in patients with iodine-131 treatment after thyroid cancer surgery[J]. Clin Med Eng, 2018, 25(6): 827-828.   doi: 10.3969/j.issn.1674-4659.2018.06.0827
[2] 赵志刚, 李长越, 谢路林, 等.  131I治疗分化型甲状腺癌患者病区环境辐射剂量率测定[J]. 临床军医杂志, 2017, 45(4): 421-422.   doi: 10.16680/j.1671-3826.2017.04.29
Zhao ZG, Li CY, Xie LL, et al.  Measurement of radiation dose rate in the ward environment of patients with differentiated thyroid cancer treated with 131I[J]. Chin J Med Offic, 2017, 45(4): 421-422.   doi: 10.16680/j.1671-3826.2017.04.29
[3] 廖光星, 李宁, 廖宁, 等.  分化型甲状腺癌术后患者131I治疗的辐射防护初探[J]. 肿瘤学杂志, 2016, 22(11): 888-892.   doi: 10.11735/j.issn.1671-170X.2016.11.B004
Liao GX, Li N, Liao N, et al.  Radiation protection of postoperative 131I treatment for patients with differentiated thyroid cancer[J]. J Chin Oncol, 2016, 22(11): 888-892.   doi: 10.11735/j.issn.1671-170X.2016.11.B004
[4] 陈春晖, 贾茹, 陈飚.  131I甲状腺癌治疗住院管理及放射防护状况调查[J]. 中国辐射卫生, 2022, 31(1): 64-69.   doi: 10.13491/j.issn.1004-714X.2022.02.012
Chen CH, Jia R, Chen B.  An investigation of hospitalization management and radiation protection in 131I treatment for thyroid cancer[J]. Chin J Radiol Health, 2022, 31(1): 64-69.   doi: 10.13491/j.issn.1004-714X.2022.02.012
[5] 彭亮, 李长越, 孟丹, 等.  分化型甲状腺癌术后放射性131I治疗对育龄期人群生育力影响研究[J]. 临床军医杂志, 2020, 48(9): 1099-1100.   doi: 10.16680/j.1671-3826.2020.09.39
Peng L, Li CY, Meng D, et al.  Study on the impact of postoperative radioactive 131I therapy on fertility in reproductive-age population with differentiated thyroid cancer[J]. Chin J Med Offic, 2020, 48(9): 1099-1100.   doi: 10.16680/j.1671-3826.2020.09.39
[6] 刘明, 耿建华, 梁颖.  核医学治疗分化型甲状腺癌场所空气中131I浓度的研究进展[J]. 中国辐射卫生, 2019, 28(6): 734-736.   doi: 10.13491/j.issn.1004-714X.2019.06.036
Liu M, Geng JH, Liang Y.  Research progress of 131I concentration in the air in the 131I thyroid carcinoma treatment site[J]. Chin J Radiol Health, 2019, 28(6): 734-736.   doi: 10.13491/j.issn.1004-714X.2019.06.036
[7] Jo K, Lim DJ.  Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer[J]. Korean J Intern Med, 2018, 33(6): 1050-1057.   doi: 10.3904/kjim.2018.289
[8]

中华人民共和国国家卫生健康委员会. GBZ 120-2020 核医学放射防护要求[S]. 北京: 中国标准出版社, 2020.

National Health Commission of the People's Republic of China. GBZ 120-2020 requirements for radiological protection in nuclear medicine[S]. Beijing: Standards Press of China, 2020.
[9] Kusakabe K, Yokoyama K, Ito K, et al.  Thyroid remnant ablation using 1, 110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy[J]. Ann Nucl Med, 2012, 26(4): 370-378.   doi: 10.1007/s12149-012-0590-7
[10] 靳平燕, 欧阳伟, 冯会娟, 等.  131I治疗分化型甲状腺癌患者的辐射剂量率研究[J]. 广东医学, 2016, 37(3): 386-388.   doi: 10.13820/j.cnki.gdyx.2016.03.016
Jin PY, Ouyang W, Feng HJ, et al.  Research on radiation dose rate of patients with differentiated thyroid cancer treated with 131I[J]. Guangdong Med J, 2016, 37(3): 386-388.   doi: 10.13820/j.cnki.gdyx.2016.03.016
[11]

中华人民共和国国家卫生健康委员会. GBZ 128-2019 职业性外照射个人监测规范[S]. 北京: 中国标准出版社, 2019.

National Health Commission of the People's Republic of China. GBZ 128-2019 Specifications for individual monitoring of occupational external exposure[S]. Beijing: Standards Press of China, 2019.
[12]

中华人民共和国国家质量监督检验检疫总局. GB 18871-2002 电离辐射防护与辐射源安全基本标准[S]. 北京: 中国标准出版社, 2004.

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China. GB 18871-2002 Basic standards for protection against ionizing radiation and for the safety of radiation sources[S]. Beijing: Standards Press of China, 2004.
[13] 王所富, 於国兵, 顾先宝, 等.  某医院核医学科不同区域不同形态131I的分布研究[J]. 标记免疫分析与临床, 2019, 26(6): 1011-1015.   doi: 10.11748/bjmy.issn.1006-1703.2019.028
Wang SF, Yu GB, Gu XB, et al.  A study of 131I distribution in different forms of nuclear medicine in a hospital[J]. Labeled Immunoassays Clin Med, 2019, 26(6): 1011-1015.   doi: 10.11748/bjmy.issn.1006-1703.2019.028
[14] 任庆余, 王琳杰, 赵进沛.  碘-131治疗分化型甲状腺癌外照射辐射剂量研究[J]. 中国职业医学, 2017, 44(5): 625-628.   doi: 10.11763/j.issn.2095-2619.2017.05.021
Ren QY, Wang LJ, Zhao JP.  Study on external exposure dose level of I-131 therapy for differentiated thyroid carcinoma[J]. China Occup Med, 2017, 44(5): 625-628.   doi: 10.11763/j.issn.2095-2619.2017.05.021
[15] 施冰梓, 杨素云.  131I治疗分化型甲状腺癌患者被服清洁解控的研究进展[J]. 护理学杂志, 2022, 37(9): 111-113.   doi: 10.3870/j.issn.1001-4152.2022.09.111
Shi BZ, Yang SY.  A review of release of bed covers and clothing after patients receiving iodine-131 for differentiated thyroid cancer[J]. J Nursing Sci, 2022, 37(9): 111-113.   doi: 10.3870/j.issn.1001-4152.2022.09.111